Last reviewed · How we verify
NCT04332029
Smoking Cessation Treatment for Smokers With Obesity
NA trial testing CBT + WGP + CM in Tobacco Use Disorder in 120 participants. Completed in 28 February 2023.
31 December 2022
Quick facts
| Lead sponsor | University of Oviedo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 7 October 2020 |
| Primary completion | 31 December 2022 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- CBT + WGP + CM
- CBT + WGP
Conditions studied
- Tobacco Use Disorder — all drugs for Tobacco Use Disorder →
Sponsor
University of Oviedo
Who can join
18 and older, any sex, with Tobacco Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to developed an empirically validated psychological intervention protocol for smoking cessation among individuals with excess weight. Participants will be assigned to one of the two following conditions: 1) Cognitive-Behavioral Treatment (CBT) for smoking cessation + a Weight Gain Prevention module (WGP); 2) the same treatment alongside Contingency Management (CM) for smoking abstinence. The main goals are: 1) to assess smoking abstinence rates in each condition at post-treatment and one, three, six and twelve month follow-ups, 2) to assess the effect of treatment conditions and abstinence on weight at each assessment point, 3) to analyze the potential moderating effect of individual variables: socio-demographic characteristics, severity of nicotine dependence and demand, disordered eating, impulsivity and emotional regulation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventions for preventing weight gain after smoking cessation.
Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, et al · · 2021 · cited 40× · PMID 34611902 · DOI 10.1002/14651858.cd006219.pub4
Verify or expand the search:
- PubMed search for NCT04332029
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tobacco Use Disorder
Currently open trials in the same condition.
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT06678672 — Contingency Management for Veteran Smokers Undergoing Major Elective Surgery · NA · recruiting
- NCT06006143 — Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2 · Phase 2 · active not recruiting
- NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
- NCT06798324 — tDCS Plus Varenicline for Smoking Cessation · Phase 4 · recruiting
Other University of Oviedo trials
Trials by the same sponsor.
- NCT07419386 — Clinical and Psychosocial Factors Associated With Physical Activity Level in Adults With Marfan Syndrome · not yet recruiting
- NCT07408765 — Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism · recruiting
- NCT07406802 — Association Between Racket Stiffness and Lateral Epicondylalgia in Tennis Players · recruiting
- NCT07408700 — Influence of Training Surface and Mechanical Load on the Prevalence of Patellofemoral Pain in Recreational Runners · recruiting
- NCT07408739 — Association Between Weekly Strength Training Load and Perceived Physical Performance in Non-Professional Soccer Players · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04332029 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oviedo
- Last refreshed: 29 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04332029.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing